Transplantation immunology encompasses the mechanisms by which the host’s immune system recognises and either rejects or tolerates genetically distinct grafts. Adaptive immunity drives acute and ...

In this podcast episode, Professor Medhat Askar discusses the revolutionary changes in transplant immunology, focusing on his research and clinical practices related to organ and bone marrow ...

The following article is an opinion piece written by Dr. David Lowe. The views and opinions expressed in this article are those of the author and do not necessarily reflect the official position of ...

Human leukocyte antigen (HLA) genotyping underpins the compatibility assessment between donor and recipient in both haematopoietic stem cell and solid-organ transplantation. Advances in sequencing ...

HLA sensitization poses a major challenge to kidney transplantation for patients with end-stage kidney disease, especially for highly sensitized candidates. Attempts at antibody elimination ...

Currently, kidney transplantation is the most effective treatment to ensure survival and improve the quality of life of patients with end-stage chronic kidney disease, and it is widely practiced in ...

IMU Biosciences, a biotechnology company using its High Definition ("HD") Immunology™ platform to decode the immune system and transform how we understand, diagnose, and treat disease, and Eurofins ...

Organ transplantation is the surgical replacement of diseased organs with healthy organs (grafts) from live or cadaver donors. The genetic relationship between the donor and the recipient is ...

The Yale Organ Transplantation and Immunology program marked a significant milestone on Dec. 10, 2025, completing its 750th liver transplant. The landmark procedure—performed by Joohyun Kim, MD; ...

In a paradigm-breaking study, researchers have discovered a novel way the immune system, specifically T cells, attack their target cells, reshaping long-held assumptions in immunology and ...

Organ transplantation is fraught with challenges, from donor shortages to eventual transplanted organ failure. The immunosuppressive drugs that are currently the standard of care following ...